| [1] |
|
| [2] |
Chincholkar M. Gabapentinoids: pharmacokinetics, pharmacodynamics and considerations for clinical practice[J]. Br J Pain, 2020, 14(2): 104-114.doi: 10.1177/2049463720912496.
|
| [3] |
Rai A, Siddique M. Re: Pregabalin and gabapentin for pain[J]. BMJ, 2020, 369(8245):242-245.doi: 10.1136/bmj.m1315.
|
| [4] |
Dalsgaard H, Dalhoff KP, Heerfordt IM. A review of the addictive potential of pregabalin and gabapentin[J]. Adverse Drug Reaction Bulletin, 2024, 347(1): 1347-1350. doi: 10.1097/FAD.0000000000000076.
|
| [5] |
Isoardi KZ, Polkinghorne G, Harris K, et al. Pregabalin poisoning and rising recreational use: A retrospective observational series[J]. Br J Clin Pharmacol, 2020, 86(12):2435-2440.doi: 10.1111/bcp.14348.
|
| [6] |
Lyndon A, Audrey S, Wells C, et al. Risk to heroin users of polydrug use of pregabalin or gabapentin[J]. Addiction, 2017, 112(9):1580-1589.doi: 10.1111/add.13843.
pmid: 28493329
|
| [7] |
Rietjens SJ, Sikma MA, Hunault CC, et al. Pregabalin poisoning: Evaluation of dose-toxicity relationship[J]. Br J Clin Pharmacol, 2022, 88(3): 1288-1297.doi: 10.1111/bcp.15073.
|
| [8] |
Bouchard J, Yates C, Calello DP, et al. Extracorporeal treatment for gabapentin and pregabalin poisoning: Systematic review and recommendations from the EXTRIP workgroup[J]. Am J Kidney Dis, 2022, 79(1):88-104.doi: 10.1053/j.ajkd.2021.06.027.
|
| [9] |
Shimazui H, Kikuchi H, Nakada TA, et al. High-flow continuous hemodiafiltration for severe pregabalin intoxication: A case report[J]. Renal Replacement Therapy, 2022, 8:60.doi: 10.1186/s41100-022-00449-w.
|
| [10] |
Lynn E, Cousins G, Lyons S, et al. A repeated cross-sectional study of factors associated with pregabalin-positive poisoning deaths in Ireland[J]. Drug Alcohol Depend, 2020, 206: 107471.doi: 10.1016/j.drugalcdep.2019.107741.
|
| [11] |
Reyes-Molón L, Gallego-Deike L. Pregabalin as a probable cause of thrombocytopenia: Presentation of two clinical cases and review of literature[J]. Actas Esp Psiquiatr, 2014, 42(1):39-40.
pmid: 24504992
|
| [12] |
Ghannoum M, Hoffman RS, Gosselin S, et al. Use of extracorporeal treatments in the management of poisonings[J]. Kidney Int, 2018, 94(4):682-688.doi: 10.1016/j.kint.2018.03.026.
pmid: 29958694
|
| [13] |
Bockbrader HN, Radulovic LL, Posvar EL, et al. Clinical pharmacokinetics of pregabalin in healthy volunteers[J]. J Clin Pharmacol, 2010, 50(8):941-950.doi: 10.1177/0091270009352087.
|
| [14] |
Nielsen VT, Wijayasinghe N, Høgberg LCG, et al. Case report: A comatose patient with pregabalin overdose successfully treated with continuous renal replacement therapy[J]. Front Med (Lausanne), 2023, 10: 1125653.doi: 10.3389/fmed.2023.1125653.
|
| [15] |
Dufayet L, Monnet F, Laborde-Casterot H, et al. Unintentional exposure to pregabalin in ≤6-year-old children: A nationwide French poison control center study[J]. Clin Toxicol (Phila), 2020, 59(5): 433-439.doi: 10.1080/15563650.2020.1822530.
|
| [16] |
Carter EJR, Kistamgari S, Hays HL, et al. Gabapentin and pregabalin exposures reported to United States poison centers, 2012-2022[J]. Inj Epidemiol, 2024, 11: 59. doi: 10.1186/s40621-024-00547-9.
pmid: 39487483
|
| [17] |
Evoy KE, Covvey JR, Peckham AM, et al. Reports of gabapentin and pregabalin abuse, misuse, dependence, or overdose: An analysis of the food and drug administration adverse events reporting system (FAERS)[J]. Res Social Adm Pharm, 2019, 15(8):953-958.doi: 10.1016/j.sapharm.2018.06.018.
pmid: 31303196
|
| [18] |
Glancy M, Palmateer N, Yeung A, et al. Risk of drug-related death associated with co-prescribing of gabapentinoids and Z-drugs among people receiving opioid-agonist treatment: A national retrospective cohort study[J]. Psychiatry Res, 2024, 339:116028.doi: 10.1016/j.psychres.2024.116028.
|
| [19] |
|
| [20] |
|
| [21] |
Jacob S, Nair AB. An updated overview on therapeutic drug monitoring of recent antiepileptic drugs[J]. Drugs R D, 2016, 16(4): 303-316.doi: 10.1007/s40268-016-0148-6.
pmid: 27766590
|
| [22] |
Wood DM, Berry DJ, Glover G, et al. Significant pregabalin toxicity managed with supportive care alone[J]. J Med Toxicol, 2010, 6(4): 435-437.doi: 10.1007/s13181-010-0052-3.
pmid: 20373065
|